ECETOC workshop on the biological significance of DNA adducts: Summary of follow-up from an Expert Panel Meeting

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 2, 2009, Pages 152-157

  Pottenger, Lynn H ^a   Carmichael, Neil ^b   Banton, Marcy I ^c   Boogaard, Peter J ^d   Kim, James ^e   Kirkland, David ^f   Phillips, Richard D ^g   van Benthem, Jan ^h   Williams, Gary M ⁱ   Castrovinci, Alexis ^j  

^a DOW CHEMICAL COMPANY   (United States)

^b European Centre for Ecotoxicology and Toxicology of Chemicals   (Belgium)

^c LYONDELLBASELL INDUSTRIES   (United States)

^d SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^e ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^f Department of Environmental Air Quality   (United Kingdom)

^g EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ NEW YORK MEDICAL COLLEGE   (United States)

^j ICF INTERNATIONAL   (United States)

more..

Author keywords

Carcinogenicity; DNA adducts; Dose response; Genotoxicity; Mode of action; Mutagenesis; Risk assessment; Thresholds; Workshop

Indexed keywords

ALKYLATING AGENT; CARCINOGEN; DNA; METHYLTRANSFERASE; MUTAGENIC AGENT; PROTEIN;

ADVERSE OUTCOME; ARTICLE; BIOLOGY; CARCINOGENESIS; CLINICAL RESEARCH; DNA ADDUCT; DOSE RESPONSE; ECOTOXICOLOGY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENOMICS; IN VITRO STUDY; INFORMATION; KNOWLEDGE BASE; MATHEMATICAL MODEL; MUTAGENESIS; NEOPLASM; PRIORITY JOURNAL; RISK ASSESSMENT; SCIENTIST; TIME;

CARCINOGENS; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUTAGENICITY TESTS; MUTAGENS; RISK ASSESSMENT;

EID: 69449101356     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.07.006     Document Type: Article

References (21)

1. Pottenger L.H., Penman M., Moore N.P., Priston R.A., and Thomas M. Biological significance of DNA adducts: summary of discussion of expert panel. Regul. Toxicol. Pharmacol. 39 (2004) 403-408
2. E.M. Tompkins, K.I.E. McLuckie, D.J.L. Jones, P.B. Farmer, K. Brown, Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells, Mutat. Res., doi:10.1016/j.mrgentox.2009.05.011, this issue.
3. 6-alkylguanine adducts in E. coli. DNA Repair 8 (2009) 697-703
4. W.K. Lutz, R.W. Lutz, Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data, Mutat. Res., doi:10.1016/j.mrgentox.2009.05.010, this issue.
5. Gaylor D.W. The ED01 study: summary and conclusions. J. Environ. Pathol. Toxicol. 3 (1980) 179-183
6. A. Brink, I. Richter, U. Lutz, P. Wanek, H. Stopper, W.K. Lutz, Biological significance of DNA adducts: comparison of increments over background for various biomarkers of genotoxicity in L5178Y tk+/- mouse lymphoma cells treated with hydrogen peroxide and cumene hydroperoxide. Mutat. Res., doi:10.1016/j.mrgentox.2009.06.001, this issue.
7. G. Johnson, S.H. Doak, S.M. Griffiths, E.L. Quick, D.O.F. Skibinski, Z.M. Zaïr, G.J. Jenkins, Non-linear dose-response of DNA-reactive genotoxins: recommendations for analysis, Mutat. Res., doi:10.1016/j.mrgentox.2009.05.009, this issue.
8. Doak S.H., Jenkins G.J.S., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007) 3904-3911
9. G. Boysen, B.F. Pachkowski, J. Nakamura, J. Swenberg, The formation and biological significance of N7-guanine adducts, Mutat. Res., doi:10.1016/j.mrgentox.2009.05.006, this issue.
10. L.H. Pottenger, M.R. Schisler, F. Zhang, M.J. Bartels, D.D. Fontaine, L.G. McFadden, B.B. Gollapudi, Dose-response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU, Mutat. Res., doi:10.1016/j.mrgentox.2009.07.002, this issue.
11. Pottenger L.H., Zhang F., Schisler M.R., Bartels M.J., Wiescinski C., Charles G., and Gollapudi B.B. Apparent thresholds for induction of DNA adducts and peripheral blood micronucleus in rats treated with MMS. Poster presentation at the 48th Annual EMS Meeting. Atlanta, GA, USA (2007) P119
12. Gant T.W. Novel and future applications of microarrays in toxicological research. Expert Opin. Drug Metab. Toxicol. 3 (2007) 599-608
13. Hockley S.L., Arlt V.M., Brewer D., te Poele R., Workman P., Giddings I., and Phillips D.H. HR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem. Res. Toxicol. 20 (2007) 1797-1810
14. Environmental Protection Agency U.S. Guidelines for Carcinogen Risk Assessment (2005) EPA/630/P-03/001F
15. Environmental Protection Agency U.S. Supplemental Guidance for Assessing Susceptibility from Early-life Exposures to Carcinogens (2005) EPA/630/R-03/003F
16. Environmental Protection Agency U.S. Draft Framework for Determining a Mutagenic Mode of Action for Carcinogenicity: Using EPA's 2005 Cancer Guidelines and Supplemental Guidance for Assessing Susceptibility from Early-life Exposure to Carcinogens External Peer Review Draft (2007) EPA 120/R-07/002A
17. E. Gocke, L. Müller. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU, Mutat. Res., doi:10.1016/j.mrgentox.2009.04.005, this issue.
18. European Chemicals Agency (ECHA). Guidance on information requirements and chemical safety assessment. Chapter R. 8: Characterisation of dose [concentration]-response for human health (2008)
19. European Food Safety Authority (EFSA). Opinion of the scientific committee on a request from EFSA related to a harmonized approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 282 (2005) 1-30
20. Boobis A.R., Cohen S.M., Dellarco V., McGreeor D., Meek M.E., Vickers C., Willcocks D., and Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 23 (2006) 781-792
21. Greim H., and Reuter U. Classification of carcinogenic chemicals in the work area by the German MAK Commission: current examples for the new categories. Toxicology 166 (2001) 11-23